找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Childhood Acute Lymphoblastic Leukemia; Ajay Vora Book 2017 Springer International Publishing Switzerland 2017 acute lymphoblastic leukemi

[復(fù)制鏈接]
查看: 30762|回復(fù): 54
樓主
發(fā)表于 2025-3-21 17:31:05 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Childhood Acute Lymphoblastic Leukemia
編輯Ajay Vora
視頻videohttp://file.papertrans.cn/226/225109/225109.mp4
概述Exhaustively reviews current therapeutic strategies and applications of precision medicine in ALL treatment.Provides scientists and clinicians with state of the art knowledge to guide their research a
圖書封面Titlebook: Childhood Acute Lymphoblastic Leukemia;  Ajay Vora Book 2017 Springer International Publishing Switzerland 2017 acute lymphoblastic leukemi
描述.This book provides a comprehensive and up-to-date review of all aspects of childhood Acute Lymphoblastic Leukemia, from basic biology to supportive care. It offers new insights into the genetic pre-disposition to the condition and discusses how response to early therapy and its basic biology are?utilized?to develop new prognostic stratification systems and target therapy...Readers will learn about current treatment and outcomes, such as immunotherapy and targeted therapy approaches.? Supportive care and management of the condition in resource poor countries are also discussed in detail...This is an indispensable guide for ?research and laboratory scientists, pediatric hematologists as well as specialist nurses involved in the care of childhood?leukemia..
出版日期Book 2017
關(guān)鍵詞acute lymphoblastic leukemia; pediatrics; hematology; genetics; cytogenetics; immunotherapy; first-line tr
版次1
doihttps://doi.org/10.1007/978-3-319-39708-5
isbn_softcover978-3-319-81947-1
isbn_ebook978-3-319-39708-5
copyrightSpringer International Publishing Switzerland 2017
The information of publication is updating

書目名稱Childhood Acute Lymphoblastic Leukemia影響因子(影響力)




書目名稱Childhood Acute Lymphoblastic Leukemia影響因子(影響力)學(xué)科排名




書目名稱Childhood Acute Lymphoblastic Leukemia網(wǎng)絡(luò)公開度




書目名稱Childhood Acute Lymphoblastic Leukemia網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Childhood Acute Lymphoblastic Leukemia被引頻次




書目名稱Childhood Acute Lymphoblastic Leukemia被引頻次學(xué)科排名




書目名稱Childhood Acute Lymphoblastic Leukemia年度引用




書目名稱Childhood Acute Lymphoblastic Leukemia年度引用學(xué)科排名




書目名稱Childhood Acute Lymphoblastic Leukemia讀者反饋




書目名稱Childhood Acute Lymphoblastic Leukemia讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:42:16 | 只看該作者
https://doi.org/10.1007/978-90-481-8704-1ave a more varied presentation. Bone pain and the signs and symptoms of mediastinal and central nervous system involvement are of particular relevance. Time to presentation for medical attention is related to presenting symptoms. In this chapter, the clinical and laboratory features of ALL at presen
板凳
發(fā)表于 2025-3-22 01:19:21 | 只看該作者
地板
發(fā)表于 2025-3-22 07:37:40 | 只看該作者
5#
發(fā)表于 2025-3-22 11:14:24 | 只看該作者
HwanSuk Chris Choi,Ercan Sirakaya Turkple effector mechanisms of the antileukemic agents that are responsible for the efficacy (Fig. 5.1 and Table 5.1). This contrasts the modern era of targeted therapy, where molecular mapping of chemoresistant cancer cells has led to development of drugs that specifically target aberrant pathways (see
6#
發(fā)表于 2025-3-22 15:20:15 | 只看該作者
Filippo M. Denaro,Giuliano De Stefano. MRD measurements have proven to be the strongest independent prognostic factor, allowing for risk-group assignment into different treatment arms, ranging from treatment reduction or intensification. MRD measurements are also guiding treatment decisions in relapsed ALL patients and patients undergo
7#
發(fā)表于 2025-3-22 18:58:34 | 只看該作者
8#
發(fā)表于 2025-3-22 23:36:52 | 只看該作者
Katherine N. Marenco,David J. Bottjergic subsets of childhood ALL and improved clinical risk stratification of patients. These genomic advances have further identified key leukaemia-associated pathways and somatic alterations that may be amenable to therapeutic targeting with kinase inhibitors and other molecularly-targeted agents. Thi
9#
發(fā)表于 2025-3-23 04:09:29 | 只看該作者
10#
發(fā)表于 2025-3-23 09:03:45 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-24 19:28
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
茂名市| 柳江县| 寿宁县| 常山县| 奉新县| 铜鼓县| 微山县| 宿松县| 淮南市| 民权县| 尼木县| 吉首市| 礼泉县| 广平县| 巴林左旗| 崇信县| 通化县| 马公市| 新郑市| 福泉市| 奈曼旗| 福鼎市| 陆丰市| 榆林市| 屏南县| 松阳县| 申扎县| 乌审旗| 枣阳市| 宁阳县| 洱源县| 博罗县| 江门市| 鲁山县| 区。| 酒泉市| 靖安县| 伊吾县| 巴南区| 那坡县| 巴青县|